Essen BioScience is a world leader in the field of cell-based in vitro assays and instrumentation. In its recent history, Essen has concentrated on imaging products with the release of the IncuCyte™ ...

RYE, N.Y.--(BUSINESS WIRE)--SFW Capital Partners, a specialized private equity firm that invests with management in mid-sized companies providing analytical tools and related services, today announced ...

Essen BioScience, a pioneer and leader in the field of cell-based assays and instrumentation used for drug discovery and basic research, has launched the IncuCyte® S3 live-cell analysis platform for ...

SFW Capital Partners has agreed to sell Essen BioScience Inc. to pharmaceutical and laboratory equipment company Sartorius Group for $320 million, nearly three years after the private-equity firm ...

* Sartorius will update its 2017 financial guidance for lab division and therefore also for Sartorius Group post closure of transaction Source text - bit.ly/2mSCzsh Further company coverage: ...

Essen BioScience: Real-Time Live-Cell Analysis Conventional approaches to cell analysis only capture a single time point, but change can happen in an instant, no matter what you’re doing.

- Enables real-time measurements of cell health, proliferation, movement and function while cells remain unperturbed in a physiologically relevant environment - Automates data capture and cell ...

The IncuCyte® Real-Time Quantitative Live-Cell Analysis System, designed by Essen BioScience, Inc. is the first system to enable quantification of cell behavior over time (from hours to weeks) by ...

Materials science is a rapidly growing area of research in journals tracked by the Nature Index and one where the real-world applications are often an essential part of tackling global environmental ...